Nick Leschly
Chairman presso 2SEVENTY BIO, INC.
Patrimonio netto: 8 M $ in data 31/03/2024
Profilo
Nick Leschly ha fondato la Medxtend Corp. Attualmente, occupa la posizione di presidente, amministratore delegato e direttore di Bluebird Bio, Inc. e amministratore delegato di FierceBiotech. È anche nel consiglio di Biotechnology Innovation Organization, Synlogic Operating Co., Inc. e Synlogic, Inc. Nella sua carriera passata è stato amministratore delegato di Medxtend Corp., amministratore delegato di Agios Pharmaceuticals, Inc. e partner di Third Rock Ventures LLC. Nick Leschly ha conseguito una laurea presso la Princeton University e un MBA presso la Wharton School dell'Università della Pennsylvania.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
2SEVENTY BIO, INC.
2.68% | 08/01/2024 | 1 376 709 ( 2.68% ) | 7 M $ | 31/03/2024 |
BLUEBIRD BIO, INC.
0.24% | 16/06/2023 | 459 638 ( 0.24% ) | 588 337 $ | 31/03/2024 |
SYNLOGIC INC
0.01% | 18/08/2023 | 1 543 ( 0.01% ) | 2 762 $ | 31/03/2024 |
Posizioni attive di Nick Leschly
Società | Posizione | Inizio |
---|---|---|
BLUEBIRD BIO, INC. | Director/Board Member | 01/03/2010 |
SYNLOGIC, INC. | Director/Board Member | 28/08/2017 |
2SEVENTY BIO, INC. | Chairman | 01/04/2024 |
FierceBiotech
FierceBiotech Commercial Printing/FormsCommercial Services FierceBiotech is an American company that publishes magazines and articles. The private company is based in Washington. The CEO of the company is Nick Leschly. | Chief Executive Officer | 21/04/2011 |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | - |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | Director/Board Member | 23/03/2016 |
Precedenti posizioni note di Nick Leschly
Società | Posizione | Fine |
---|---|---|
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Private Equity Investor | 30/06/2009 |
Medxtend Corp. | Chief Executive Officer | 01/03/2001 |
Proclara Biosciences, Inc.
Proclara Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Proclara Biosciences, Inc. provides treatment of chronic neurodegenerative diseases. The firm develops therapies for protein misfolding diseases, such as chronic diseases of aging and certain orphan indications by harnessing General Amyloid Interaction Motif (GAIM), which is a multi-target approach that reduces levels of pathological misfolded protein deposits. The company was founded by Hampus Jacob Hillerstrom and Jonathan Eithan Solomon in December 2006 and is headquartered in Cambridge, MA. | Director/Board Member | - |
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formazione di Nick Leschly
Princeton University | Undergraduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 4 |
---|---|
AGIOS PHARMACEUTICALS, INC. | Health Technology |
BLUEBIRD BIO, INC. | Health Technology |
SYNLOGIC, INC. | Health Technology |
2SEVENTY BIO, INC. | Health Technology |
Aziende private | 7 |
---|---|
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Proclara Biosciences, Inc.
Proclara Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Proclara Biosciences, Inc. provides treatment of chronic neurodegenerative diseases. The firm develops therapies for protein misfolding diseases, such as chronic diseases of aging and certain orphan indications by harnessing General Amyloid Interaction Motif (GAIM), which is a multi-target approach that reduces levels of pathological misfolded protein deposits. The company was founded by Hampus Jacob Hillerstrom and Jonathan Eithan Solomon in December 2006 and is headquartered in Cambridge, MA. | Health Technology |
FierceBiotech
FierceBiotech Commercial Printing/FormsCommercial Services FierceBiotech is an American company that publishes magazines and articles. The private company is based in Washington. The CEO of the company is Nick Leschly. | Commercial Services |
Edimer Pharmaceuticals, Inc.
Edimer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Edimer Pharmaceuticals, Inc. provides biopharmaceutical products for improving the health and quality of life of families living with XLHED. It has developed EDI200 as a treatment for X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), which is a rare orphan disease that causes symptoms including lack of sweat glands, poor temperature control, respiratory problems, and hair and tooth malformations. The company was founded by Pascal Schneider and Olivier Gaide in 2009 and is headquartered in Cambridge, MA. | Health Technology |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | Health Technology |
Medxtend Corp. | |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Finance |
- Borsa valori
- Insiders
- Nick Leschly